We are live on ! Find out more
SGI

Summit Global Investments Portfolio holdings

AUM $1.83B
1-Year Est. Return 22.56%
This Fund
S&P 500
This Quarter Est. Return
-10.86%
1 Year Est. Return
+22.56%
3 Year Est. Return
+60.44%
5 Year Est. Return
+82.72%
10 Year Est. Return
AUM
$646M
AUM Growth
-$99M
Cap. Flow
-$12M
Cap. Flow %
-1.86%
Top 10 Hldgs %
22.73%
Holding
337
New
83
Increased
94
Reduced
65
Closed
86

Top Buys

Rank Stock Value
1
NVR icon
NVR
NVR
+$14.3M
2
EVRG icon
Evergy
EVRG
+$12M
3
BMY icon
Bristol-Myers Squibb
BMY
+$11.2M
4
NFG icon
National Fuel Gas
NFG
+$10.7M
5
TTC icon
Toro Company
TTC
+$10.1M

Sector Composition

Rank Sector Weight
1 Technology 14.7%
2 Consumer Staples 13.17%
3 Financials 13.01%
4 Consumer Discretionary 12.45%
5 Industrials 12.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JAZZ icon
101
Jazz Pharmaceuticals
JAZZ
$16.4B
$992K 0.15%
+8,000
New +$1.19M
RF icon
102
Regions Financial
RF
$27.2B
$978K 0.15%
73,120
+19,315
+36% +$310K
TROW icon
103
T. Rowe Price
TROW
$24.5B
$969K 0.15%
10,501
-42,838
-80% -$4.16M
BRK.B icon
104
Berkshire Hathaway Class B
BRK.B
$1.12T
$964K 0.15%
4,724
-270
-5% -$56.4K
CLX icon
105
Clorox
CLX
$12.8B
$949K 0.15%
6,157
-709
-10% -$110K
RMD icon
106
ResMed
RMD
$32.5B
$893K 0.14%
7,840
-490
-6% -$52.5K
SNN icon
107
Smith & Nephew
SNN
$12.7B
$890K 0.14%
23,820
CB icon
108
Chubb
CB
$136B
$872K 0.14%
6,750
-7
-0.1% -$905
SNY icon
109
Sanofi
SNY
$103B
$871K 0.13%
20,068
+3
+0% +$132
CCI icon
110
Crown Castle
CCI
$32.3B
$843K 0.13%
7,760
-200
-3% -$22K
CL icon
111
Colgate-Palmolive
CL
$74.4B
$832K 0.13%
13,981
-62,664
-82% -$3.92M
KO icon
112
Coca-Cola
KO
$374B
$830K 0.13%
17,530
-2,300
-12% -$110K
NVO
113
Novo Nordisk
NVO
$197B
$817K 0.13%
35,454
+4
+0% +$89
SYK icon
114
Stryker
SYK
$129B
$806K 0.12%
5,140
-100
-2% -$16.7K
TU icon
115
Telus
TU
$15.4B
$795K 0.12%
47,976
+6
+0% +$104
V icon
116
Visa
V
$688B
$793K 0.12%
6,007
-431
-7% -$59.5K
UN
117
DELISTED
Unilever NV New York Registry Shares
UN
$790K 0.12%
14,690
-900
-6% -$49.1K
MRSH
118
Marsh
MRSH
$91.4B
$779K 0.12%
9,768
-72,159
-88% -$6.02M
BCE icon
119
BCE
BCE
$20.6B
$778K 0.12%
19,672
+2
+0% +$82
UNP icon
120
Union Pacific
UNP
$176B
$778K 0.12%
5,625
-600
-10% -$88.9K
NTR icon
121
Nutrien
NTR
$32.1B
$770K 0.12%
16,385
CHKP icon
122
Check Point Software Technologies
CHKP
$12.8B
$764K 0.12%
7,441
-809
-10% -$88.8K
RY icon
123
Royal Bank of Canada
RY
$294B
$756K 0.12%
11,035
EQIX icon
124
Equinix
EQIX
$104B
$751K 0.12%
2,130
ADBE icon
125
Adobe
ADBE
$103B
$745K 0.12%
3,294
-5,264
-62% -$1.27M

Similar funds

Summit Global Investments's Q4 2018 Portfolio in Review

As of Q4 2018, Summit Global Investments held 337 positions worth $646M, down 13% from $745M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Summit Global Investments's Q4 2018 filing shows 83 new, 94 increased, 65 reduced and 86 closed positions. Its largest new stake was NVR: 6,069 shares worth $14.8M. The largest sale was Intuit, an estimated $14.1M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 21% a quarter earlier, followed by Consumer Staples and Financials.

  • Summit Global Investments's largest Q4 2018 buy was NVR: 6,069 shares worth $14.8M.
  • Summit Global Investments added most to Bristol-Myers Squibb in Q4 2018, an estimated $11.2M increase.
  • Summit Global Investments's biggest Q4 2018 reduction was Intuit, cutting an estimated $14.1M.
  • Summit Global Investments fully exited Madison Square Garden in Q4 2018, selling an estimated $10.5M.
  • Summit Global Investments's ten largest holdings make up 23% of its $646M portfolio in Q4 2018.
  • Summit Global Investments opened 83 new positions and closed 86 in Q4 2018.
  • Summit Global Investments's portfolio value fell 13% quarter-over-quarter to $646M.

Based on Summit Global Investments's 13F filing for Q4 2018, filed 8 Feb 2019.